<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta name="generator" content="quarto-1.0.37">
<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">
<title>SCOPE DCC Analytic Plan - 9&nbsp; Background</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
pre > code.sourceCode { white-space: pre; position: relative; }
pre > code.sourceCode > span { display: inline-block; line-height: 1.25; }
pre > code.sourceCode > span:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode > span { color: inherit; text-decoration: inherit; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
pre > code.sourceCode { white-space: pre-wrap; }
pre > code.sourceCode > span { text-indent: -5em; padding-left: 5em; }
}
pre.numberSource code
  { counter-reset: source-line 0; }
pre.numberSource code > span
  { position: relative; left: -4em; counter-increment: source-line; }
pre.numberSource code > span > a:first-child::before
  { content: counter(source-line);
    position: relative; left: -1em; text-align: right; vertical-align: baseline;
    border: none; display: inline-block;
    -webkit-touch-callout: none; -webkit-user-select: none;
    -khtml-user-select: none; -moz-user-select: none;
    -ms-user-select: none; user-select: none;
    padding: 0 4px; width: 4em;
    color: #aaaaaa;
  }
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa;  padding-left: 4px; }
div.sourceCode
  {   }
@media screen {
pre > code.sourceCode > span > a:first-child::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } /* Alert */
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } /* Annotation */
code span.at { color: #7d9029; } /* Attribute */
code span.bn { color: #40a070; } /* BaseN */
code span.bu { } /* BuiltIn */
code span.cf { color: #007020; font-weight: bold; } /* ControlFlow */
code span.ch { color: #4070a0; } /* Char */
code span.cn { color: #880000; } /* Constant */
code span.co { color: #60a0b0; font-style: italic; } /* Comment */
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } /* CommentVar */
code span.do { color: #ba2121; font-style: italic; } /* Documentation */
code span.dt { color: #902000; } /* DataType */
code span.dv { color: #40a070; } /* DecVal */
code span.er { color: #ff0000; font-weight: bold; } /* Error */
code span.ex { } /* Extension */
code span.fl { color: #40a070; } /* Float */
code span.fu { color: #06287e; } /* Function */
code span.im { } /* Import */
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } /* Information */
code span.kw { color: #007020; font-weight: bold; } /* Keyword */
code span.op { color: #666666; } /* Operator */
code span.ot { color: #007020; } /* Other */
code span.pp { color: #bc7a00; } /* Preprocessor */
code span.sc { color: #4070a0; } /* SpecialChar */
code span.ss { color: #bb6688; } /* SpecialString */
code span.st { color: #4070a0; } /* String */
code span.va { color: #19177c; } /* Variable */
code span.vs { color: #4070a0; } /* VerbatimString */
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } /* Warning */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>

<script src="site_libs/quarto-nav/quarto-nav.js"></script>
<script src="site_libs/quarto-nav/headroom.min.js"></script>
<script src="site_libs/clipboard/clipboard.min.js"></script>
<script src="site_libs/quarto-search/autocomplete.umd.js"></script>
<script src="site_libs/quarto-search/fuse.min.js"></script>
<script src="site_libs/quarto-search/quarto-search.js"></script>
<meta name="quarto:offset" content="./">
<link href="./23_interested_variables.html" rel="next">
<link href="./20_study_overview.html" rel="prev">
<link href="./SOM_c_clr.png" rel="icon" type="image/png">
<script src="site_libs/quarto-html/quarto.js"></script>
<script src="site_libs/quarto-html/popper.min.js"></script>
<script src="site_libs/quarto-html/tippy.umd.min.js"></script>
<script src="site_libs/quarto-html/anchor.min.js"></script>
<link href="site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="site_libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" class="quarto-color-scheme" id="quarto-text-highlighting-styles">
<link href="site_libs/quarto-html/quarto-syntax-highlighting-dark.css" rel="prefetch" class="quarto-color-scheme quarto-color-alternate" id="quarto-text-highlighting-styles">
<script src="site_libs/bootstrap/bootstrap.min.js"></script>
<link href="site_libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="site_libs/bootstrap/bootstrap.min.css" rel="stylesheet" class="quarto-color-scheme" id="quarto-bootstrap" data-mode="light">
<link href="site_libs/bootstrap/bootstrap-dark.min.css" rel="prefetch" class="quarto-color-scheme quarto-color-alternate" id="quarto-bootstrap" data-mode="dark"><script id="quarto-search-options" type="application/json">{
  "location": "navbar",
  "copy-button": false,
  "collapse-after": 3,
  "panel-placement": "end",
  "type": "overlay",
  "limit": 20,
  "language": {
    "search-no-results-text": "No results",
    "search-matching-documents-text": "matching documents",
    "search-copy-link-title": "Copy link to search",
    "search-hide-matches-text": "Hide additional matches",
    "search-more-match-text": "more match in this document",
    "search-more-matches-text": "more matches in this document",
    "search-clear-button-title": "Clear",
    "search-detached-cancel-button-title": "Cancel",
    "search-submit-button-title": "Submit"
  }
}</script><link href="site_libs/pagedtable-1.1/css/pagedtable.css" rel="stylesheet">
<script src="site_libs/pagedtable-1.1/js/pagedtable.js"></script>
</head>
<body class="nav-sidebar floating nav-fixed">


<div id="quarto-search-results"></div>
  <header id="quarto-header" class="headroom fixed-top"><nav class="navbar navbar-expand-lg navbar-dark "><div class="navbar-container container-fluid">
      <a class="navbar-brand" href="./index.html">
    <span class="navbar-title">SCOPE DCC Analytic Plan</span>
  </a>
          <div class="quarto-toggle-container ms-auto">
              <a href="" class="quarto-color-scheme-toggle nav-link" onclick="window.quartoToggleColorScheme(); return false;" title="Toggle dark mode"><i class="bi"></i></a>
              <a href="" class="quarto-reader-toggle nav-link" onclick="window.quartoToggleReader(); return false;" title="Toggle reader mode">
  <div class="quarto-reader-toggle-btn">
  <i class="bi"></i>
  </div>
</a>
          </div>
          <div id="quarto-search" class="" title="Search"></div>
      </div> <!-- /container-fluid -->
    </nav><nav class="quarto-secondary-nav" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar" aria-controls="quarto-sidebar" aria-expanded="false" aria-label="Toggle sidebar navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }"><div class="container-fluid d-flex justify-content-between">
      <h1 class="quarto-secondary-nav-title">
<span class="chapter-number">9</span>&nbsp; <span class="chapter-title">Background</span>
</h1>
      <button type="button" class="quarto-btn-toggle btn" aria-label="Show secondary navigation">
        <i class="bi bi-chevron-right"></i>
      </button>
    </div>
  </nav></header><!-- content --><div id="quarto-content" class="quarto-container page-columns page-rows-contents page-layout-article page-navbar">
<!-- sidebar -->
  <nav id="quarto-sidebar" class="sidebar collapse sidebar-navigation floating overflow-auto"><div class="mt-2 flex-shrink-0 align-items-center">
        <div class="sidebar-search">
        <div id="quarto-search" class="" title="Search"></div>
        </div>
        <div class="sidebar-tools-collapse tools-wide">
    <a href="https://github.com/Goodgolden/scope_dcc" title="" class="sidebar-tool px-1"><i class="bi bi-github"></i></a>
    <a href="https://medschool.cuanschutz.edu/health-care-policy-and-research" title="" class="sidebar-tool px-1"><i class="bi bi-info-circle"></i></a>
    <a href="https://coloradosph.cuanschutz.edu/education/departments/biostatistics-informatics" title="" class="sidebar-tool px-1"><i class="bi bi-hospital"></i></a>
</div>
      </div>
    <div class="sidebar-menu-container"> 
    <ul class="list-unstyled mt-1">
<li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./index.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">1</span>&nbsp; <span class="chapter-title">Read Me First</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./00_activity_log.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">2</span>&nbsp; <span class="chapter-title">Activity Log</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./00_sap_revisions.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">3</span>&nbsp; <span class="chapter-title">SAP revisions</span></a>
  </div>
</li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a href="./10_administrative_information.html" class="sidebar-item-text sidebar-link">Administrative Information</a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-1" aria-expanded="true">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-1" class="collapse list-unstyled sidebar-section depth1 show">
<li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./11_study_information.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">4</span>&nbsp; <span class="chapter-title">Study Information</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./12_roles_and_responsibilities.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">5</span>&nbsp; <span class="chapter-title">Responsibilities</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./14_project_information.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">6</span>&nbsp; <span class="chapter-title">Project Information</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./15_investigator_agreement.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">7</span>&nbsp; <span class="chapter-title">Investigator Agreement</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./16_signatures.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">8</span>&nbsp; <span class="chapter-title">Signatures</span></a>
  </div>
</li>
      </ul>
</li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a href="./20_study_overview.html" class="sidebar-item-text sidebar-link">Study Overview</a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-2" aria-expanded="true">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-2" class="collapse list-unstyled sidebar-section depth1 show">
<li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./21_background.html" class="sidebar-item-text sidebar-link active"><span class="chapter-number">9</span>&nbsp; <span class="chapter-title">Background</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./23_interested_variables.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">10</span>&nbsp; <span class="chapter-title">Preliminary Data</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./25_inclusion_exclusion.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">11</span>&nbsp; <span class="chapter-title">Inclusion Exclusion</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./26_recruitment.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">12</span>&nbsp; <span class="chapter-title">Recruitment Methods</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./27_site.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">13</span>&nbsp; <span class="chapter-title">Multi-Site Research</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./28_timeline.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">14</span>&nbsp; <span class="chapter-title">Timeline</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./29_stopping.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">15</span>&nbsp; <span class="chapter-title">Study Endpoints</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./22_aims_and_hypotheses.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">16</span>&nbsp; <span class="chapter-title">Aims and Hypotheses</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./24_causal_dag.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">17</span>&nbsp; <span class="chapter-title">Causal Dag</span></a>
  </div>
</li>
      </ul>
</li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a href="./30_study_design.html" class="sidebar-item-text sidebar-link">Study Methods</a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-3" aria-expanded="true">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-3" class="collapse list-unstyled sidebar-section depth1 show">
<li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./36_randomize.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">18</span>&nbsp; <span class="chapter-title">Randomization</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./37_fidelity.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">19</span>&nbsp; <span class="chapter-title">Fidelity of Design</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./38_measures.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">20</span>&nbsp; <span class="chapter-title">Study Measures</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./31_sample_size.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">21</span>&nbsp; <span class="chapter-title">Sample Size</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./32_interim_analyses.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">22</span>&nbsp; <span class="chapter-title">Interim Analysis</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./33_data.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">23</span>&nbsp; <span class="chapter-title">Data Information</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./34_missing_data.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">24</span>&nbsp; <span class="chapter-title">Missing Data</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./35_subjects.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">25</span>&nbsp; <span class="chapter-title">Subjects</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./39_provisions_safety.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">26</span>&nbsp; <span class="chapter-title">Safety of Subjects</span></a>
  </div>
</li>
      </ul>
</li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a href="./40_statistical_analysis.html" class="sidebar-item-text sidebar-link">Statistical Analysis</a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-4" aria-expanded="true">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-4" class="collapse list-unstyled sidebar-section depth1 show">
<li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./41_descriptive_statistics.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">27</span>&nbsp; <span class="chapter-title">Descriptive Statistics</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./42_analysis_methods.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">28</span>&nbsp; <span class="chapter-title">Analysis Methods</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./43_additional.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">29</span>&nbsp; <span class="chapter-title">Additional Analysis</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./43_sensitivity_analysis.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">30</span>&nbsp; <span class="chapter-title">Sensitivity Analysis</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./44_exploratory_analysis.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">31</span>&nbsp; <span class="chapter-title">Exploratory Analysis</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./47_simulations.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">32</span>&nbsp; <span class="chapter-title">Simulation Study</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./45_software.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">33</span>&nbsp; <span class="chapter-title">Software and Packages</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./46_others.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">34</span>&nbsp; <span class="chapter-title">Other Information</span></a>
  </div>
</li>
      </ul>
</li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a href="./50_tables_shells.html" class="sidebar-item-text sidebar-link">Tables Functions</a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-5" aria-expanded="true">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-5" class="collapse list-unstyled sidebar-section depth1 show">
<li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./51_a_tables.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">35</span>&nbsp; <span class="chapter-title">Tables</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./52_figures.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">36</span>&nbsp; <span class="chapter-title">Figures</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./53_examples.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">37</span>&nbsp; <span class="chapter-title">Example</span></a>
  </div>
</li>
      </ul>
</li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a href="./60_additional_information.html" class="sidebar-item-text sidebar-link">Additional Information</a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-6" aria-expanded="true">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-6" class="collapse list-unstyled sidebar-section depth1 show">
<li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./61_appendices.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">38</span>&nbsp; <span class="chapter-title">Appencies</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./62_glossary.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">39</span>&nbsp; <span class="chapter-title">Glossary</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./63_addenda.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">40</span>&nbsp; <span class="chapter-title">Addenda</span></a>
  </div>
</li>
      </ul>
</li>
        <li class="sidebar-item sidebar-item-section">
      <span class="sidebar-item-text sidebar-link text-start">References</span>
  </li>
    </ul>
</div>
</nav><!-- margin-sidebar --><div id="quarto-margin-sidebar" class="sidebar margin-sidebar">
        <nav id="TOC" role="doc-toc"><h2 id="toc-title">Table of contents</h2>
   
  <ul>
<li>
<a href="#sec-background" id="toc-sec-background" class="nav-link active" data-scroll-target="#sec-background"> <span class="header-section-number">9.1</span> Scientific Background</a>
  <ul class="collapse">
<li><a href="#patients-with-aml-have-a-sudden-life-threatening-illness-requiring-urgent-therapy" id="toc-patients-with-aml-have-a-sudden-life-threatening-illness-requiring-urgent-therapy" class="nav-link" data-scroll-target="#patients-with-aml-have-a-sudden-life-threatening-illness-requiring-urgent-therapy"> <span class="header-section-number">9.1.1</span> Patients with AML have a sudden life-threatening illness requiring urgent therapy</a></li>
  <li><a href="#patients-with-aml-face-substantial-physical-and-psychological-symptoms" id="toc-patients-with-aml-face-substantial-physical-and-psychological-symptoms" class="nav-link" data-scroll-target="#patients-with-aml-face-substantial-physical-and-psychological-symptoms"> <span class="header-section-number">9.1.2</span> Patients with AML face substantial physical and psychological symptoms</a></li>
  <li><a href="#patients-with-aml-face-difficult-decisions-about-treatment" id="toc-patients-with-aml-face-difficult-decisions-about-treatment" class="nav-link" data-scroll-target="#patients-with-aml-face-difficult-decisions-about-treatment"> <span class="header-section-number">9.1.3</span> Patients with AML face difficult decisions about treatment</a></li>
  <li><a href="#patients-with-aml-rarely-discuss-their-end-of-life-eol-care-preferences" id="toc-patients-with-aml-rarely-discuss-their-end-of-life-eol-care-preferences" class="nav-link" data-scroll-target="#patients-with-aml-rarely-discuss-their-end-of-life-eol-care-preferences"> <span class="header-section-number">9.1.4</span> Patients with AML rarely discuss their end-of-life (EOL) care preferences</a></li>
  <li><a href="#caregivers-of-patients-with-aml-experience-tremendous-burden-and-distress" id="toc-caregivers-of-patients-with-aml-experience-tremendous-burden-and-distress" class="nav-link" data-scroll-target="#caregivers-of-patients-with-aml-experience-tremendous-burden-and-distress"> <span class="header-section-number">9.1.5</span> Caregivers of patients with AML experience tremendous burden and distress</a></li>
  <li><a href="#specialty-palliative-care-improves-outcomes-for-patients-and-their-caregivers" id="toc-specialty-palliative-care-improves-outcomes-for-patients-and-their-caregivers" class="nav-link" data-scroll-target="#specialty-palliative-care-improves-outcomes-for-patients-and-their-caregivers"> <span class="header-section-number">9.1.6</span> Specialty palliative care improves outcomes for patients and their caregivers</a></li>
  <li><a href="#specialty-pc-is-not-an-accessible-or-scalable-care-model" id="toc-specialty-pc-is-not-an-accessible-or-scalable-care-model" class="nav-link" data-scroll-target="#specialty-pc-is-not-an-accessible-or-scalable-care-model"> <span class="header-section-number">9.1.7</span> Specialty PC is not an accessible or scalable care model</a></li>
  <li><a href="#primary-pc-may-be-an-alternative-care-model-to-specialty-pc" id="toc-primary-pc-may-be-an-alternative-care-model-to-specialty-pc" class="nav-link" data-scroll-target="#primary-pc-may-be-an-alternative-care-model-to-specialty-pc"> <span class="header-section-number">9.1.8</span> Primary PC may be an alternative care model to specialty PC</a></li>
  </ul>
</li>
  <li>
<a href="#sec-resources" id="toc-sec-resources" class="nav-link" data-scroll-target="#sec-resources"> <span class="header-section-number">9.2</span> Resources Available</a>
  <ul class="collapse">
<li><a href="#team-qualifications-and-oversight" id="toc-team-qualifications-and-oversight" class="nav-link" data-scroll-target="#team-qualifications-and-oversight"> <span class="header-section-number">9.2.1</span> Team Qualifications and Oversight</a></li>
  <li><a href="#other-resources" id="toc-other-resources" class="nav-link" data-scroll-target="#other-resources"> <span class="header-section-number">9.2.2</span> Other Resources</a></li>
  </ul>
</li>
  </ul><div class="toc-actions"><div><i class="bi bi-github"></i></div><div class="action-links"><p><a href="https://github.com/Goodgolden/scope_dcc/edit/main/21_background.qmd" class="toc-action">Edit this page</a></p><p><a href="https://github.com/Goodgolden/scope_dcc/issues/new" class="toc-action">Report an issue</a></p></div></div></nav>
    </div>
<!-- main -->
<main class="content" id="quarto-document-content"><header id="title-block-header" class="quarto-title-block default"><div class="quarto-title">
<div class="quarto-title-block"><div><h1 class="title d-none d-lg-block">
<span class="chapter-number">9</span>&nbsp; <span class="chapter-title">Background</span>
</h1><button type="button" class="btn code-tools-button" id="quarto-code-tools-source"><i class="bi"></i> Code</button></div></div>
</div>



<div class="quarto-title-meta">

    
    
  </div>
  

</header><div class="cell">
<style type="text/css">
.scroll-100 {
  max-height: 300px;
  max-width: 1000px;
  overflow-y: auto;
  background-color: inherit;
}
</style>
</div>
<section id="sec-background" class="level2" data-number="9.1"><h2 data-number="9.1" class="anchored" data-anchor-id="sec-background">
<span class="header-section-number">9.1</span> Scientific Background</h2>
<section id="patients-with-aml-have-a-sudden-life-threatening-illness-requiring-urgent-therapy" class="level3" data-number="9.1.1"><h3 data-number="9.1.1" class="anchored" data-anchor-id="patients-with-aml-have-a-sudden-life-threatening-illness-requiring-urgent-therapy">
<span class="header-section-number">9.1.1</span> Patients with AML have a sudden life-threatening illness requiring urgent therapy</h3>
<p>AML is an aggressive disease, characterized by an abrupt onset, an urgent need to initiate treatment, and a poor prognosis with 80% risk of death at five years <span class="citation" data-cites="alibhai2007impact alibhai2015quality burnett2010attempts walter2020selection vey2020low">(<a href="70_references.html#ref-alibhai2007impact" role="doc-biblioref">Alibhai et al. 2007</a>, <a href="70_references.html#ref-alibhai2015quality" role="doc-biblioref">2015</a>; <a href="70_references.html#ref-burnett2010attempts" role="doc-biblioref">Burnett et al. 2010</a>; <a href="70_references.html#ref-walter2020selection" role="doc-biblioref">Walter and Estey 2020</a>; <a href="70_references.html#ref-vey2020low" role="doc-biblioref">Vey 2020</a>)</span>. Most patients with AML are treated with chemotherapy drugs that require hospitalization due to significant toxicities and potentially life-threatening complications, such as bleeding and sepsis <span class="citation" data-cites="rodin2013traumatic zimmermann2013symptom zittoun1999assessment eljawahri2015health">(<a href="70_references.html#ref-rodin2013traumatic" role="doc-biblioref">Rodin et al. 2013</a>; <a href="70_references.html#ref-zimmermann2013symptom" role="doc-biblioref">Zimmermann et al. 2013</a>; <a href="70_references.html#ref-zittoun1999assessment" role="doc-biblioref">Zittoun, Achard, and Ruszniewski 1999</a>; <a href="70_references.html#ref-eljawahri2015health" role="doc-biblioref">A. R. El-Jawahri et al. 2015a</a>)</span>. Patients with AML often present to medical attention without prodromal symptoms, so they are quite shocked to learn that they have a life-threatening illness and must be immediately hospitalized to receive intensive chemotherapy <span class="citation" data-cites="alibhai2007impact alibhai2015quality burnett2010attempts">(<a href="70_references.html#ref-alibhai2007impact" role="doc-biblioref">Alibhai et al. 2007</a>, <a href="70_references.html#ref-alibhai2015quality" role="doc-biblioref">2015</a>; <a href="70_references.html#ref-burnett2010attempts" role="doc-biblioref">Burnett et al. 2010</a>)</span>.</p>
</section><section id="patients-with-aml-face-substantial-physical-and-psychological-symptoms" class="level3" data-number="9.1.2"><h3 data-number="9.1.2" class="anchored" data-anchor-id="patients-with-aml-face-substantial-physical-and-psychological-symptoms">
<span class="header-section-number">9.1.2</span> Patients with AML face substantial physical and psychological symptoms</h3>
<p>During their hospitalization for chemotherapy, patients with AML often experience difficult physical symptoms, including fevers, fatigue, pain, insomnia, mucositis, nausea, vomiting, and diarrhea that negatively impact their quality of life (QOL) and physical function <span class="citation" data-cites="rodin2013traumatic zimmermann2013symptom zittoun1999assessment eljawahri2015health eljawahri2019quality loh2019health wiese2018unmet">(<a href="70_references.html#ref-rodin2013traumatic" role="doc-biblioref">Rodin et al. 2013</a>; <a href="70_references.html#ref-zimmermann2013symptom" role="doc-biblioref">Zimmermann et al. 2013</a>; <a href="70_references.html#ref-zittoun1999assessment" role="doc-biblioref">Zittoun, Achard, and Ruszniewski 1999</a>; <a href="70_references.html#ref-eljawahri2015health" role="doc-biblioref">A. R. El-Jawahri et al. 2015a</a>; <a href="70_references.html#ref-eljawahri2019quality" role="doc-biblioref">A. El-Jawahri et al. 2019</a>; <a href="70_references.html#ref-loh2019health" role="doc-biblioref">Loh et al. 2019</a>; <a href="70_references.html#ref-wiese2018unmet" role="doc-biblioref">Wiese and Daver 2018</a>)</span>. Psychological symptoms are also quite prominent in these patients, with over one-third experiencing acute stress reactions from the shock of their diagnosis and need for urgent hospitalization <span class="citation" data-cites="rodin2013traumatic zimmermann2013symptom zittoun1999assessment eljawahri2015health eljawahri2019quality loh2019health wiese2018unmet nissim2013abducted papadopoulou2013experience farsi2012coping nissim2014bearings gheihman2015depression ghodraty2015coping ghodraty2015oneday">(<a href="70_references.html#ref-rodin2013traumatic" role="doc-biblioref">Rodin et al. 2013</a>; <a href="70_references.html#ref-zimmermann2013symptom" role="doc-biblioref">Zimmermann et al. 2013</a>; <a href="70_references.html#ref-zittoun1999assessment" role="doc-biblioref">Zittoun, Achard, and Ruszniewski 1999</a>; <a href="70_references.html#ref-eljawahri2015health" role="doc-biblioref">A. R. El-Jawahri et al. 2015a</a>; <a href="70_references.html#ref-eljawahri2019quality" role="doc-biblioref">A. El-Jawahri et al. 2019</a>; <a href="70_references.html#ref-loh2019health" role="doc-biblioref">Loh et al. 2019</a>; <a href="70_references.html#ref-wiese2018unmet" role="doc-biblioref">Wiese and Daver 2018</a>; <a href="70_references.html#ref-nissim2013abducted" role="doc-biblioref">Nissim et al. 2013</a>, <a href="70_references.html#ref-nissim2014bearings" role="doc-biblioref">2014</a>; <a href="70_references.html#ref-papadopoulou2013experience" role="doc-biblioref">Papadopoulou, Johnston, and Themessl-Huber 2013</a>; <a href="70_references.html#ref-farsi2012coping" role="doc-biblioref">Farsi, Nayeri, and Negarandeh 2012</a>; <a href="70_references.html#ref-gheihman2015depression" role="doc-biblioref">Gheihman et al. 2015</a>; <a href="70_references.html#ref-ghodraty2015coping" role="doc-biblioref">V. Ghodraty-Jabloo et al. 2015</a>; <a href="70_references.html#ref-ghodraty2015oneday" role="doc-biblioref">Vida Ghodraty-Jabloo et al. 2015</a>)</span>. Notably, the psychological burden during this hospitalization also impacts patients’ long-term QOL, mood, and adaptation to their illness <span class="citation" data-cites="ghodraty2015coping ghodraty2015oneday">(<a href="70_references.html#ref-ghodraty2015coping" role="doc-biblioref">V. Ghodraty-Jabloo et al. 2015</a>; <a href="70_references.html#ref-ghodraty2015oneday" role="doc-biblioref">Vida Ghodraty-Jabloo et al. 2015</a>)</span>. Up to 40% of patients with AML suffer from post-traumatic stress symptoms due to the trauma of their diagnosis <span class="citation" data-cites="smith1999ptsd jacobsen1998ptsd jacobsen2002predictors mundy2000ptsd">(<a href="70_references.html#ref-smith1999ptsd" role="doc-biblioref">Smith et al. 1999</a>; <a href="70_references.html#ref-jacobsen1998ptsd" role="doc-biblioref">Jacobsen et al. 1998</a>, <a href="70_references.html#ref-jacobsen2002predictors" role="doc-biblioref">2002</a>; <a href="70_references.html#ref-mundy2000ptsd" role="doc-biblioref">Mundy et al. 2000</a>)</span>.Therefore, addressing the physical and psychological needs of hospitalized patients with AML has the potential to improve their outcomes significantly both during their hospitalization and in the long-term.</p>
</section><section id="patients-with-aml-face-difficult-decisions-about-treatment" class="level3" data-number="9.1.3"><h3 data-number="9.1.3" class="anchored" data-anchor-id="patients-with-aml-face-difficult-decisions-about-treatment">
<span class="header-section-number">9.1.3</span> Patients with AML face difficult decisions about treatment</h3>
<p>Many treatments are available that offer a chance of cure for patients with AML, including stem cell transplant. However, the chance of cure is small and most patients with AML unfortunately die of their illness <span class="citation" data-cites="schlenk2017relapsed ganzel2018poor">(<a href="70_references.html#ref-schlenk2017relapsed" role="doc-biblioref">Schlenk et al. 2017</a>; <a href="70_references.html#ref-ganzel2018poor" role="doc-biblioref">Ganzel et al. 2018</a>)</span>. Consequently, to make informed decisions about whether to receive additional treatment, patients with AML must understand their prognosis and likelihood of cure <span class="citation" data-cites="eljawahri2020palliative eljawahri2018discordance">(<a href="70_references.html#ref-eljawahri2020palliative" role="doc-biblioref">A. El-Jawahri et al. 2020</a>, <a href="70_references.html#ref-eljawahri2018discordance" role="doc-biblioref">2018</a>)</span>. Unfortunately, data suggest that 90% of patients with AML report overly optimistic estimates of their prognosis <span class="citation" data-cites="eljawahri2018discordance">(<a href="70_references.html#ref-eljawahri2018discordance" role="doc-biblioref">A. El-Jawahri et al. 2018</a>)</span>. Thus, they are unprepared to make difficult decisions that require them to balance the risks and benefits of treatments that offer an uncertain chance of cure, but will worsen their QOL and require them to spend additional time in the hospital <span class="citation" data-cites="eljawahri2015health">(<a href="70_references.html#ref-eljawahri2015health" role="doc-biblioref">A. R. El-Jawahri et al. 2015a</a>)</span>. Therefore, patients with AML face considerable uncertainty and often misunderstand their prognosis, limiting their ability to make informed decisions about treatment.</p>
</section><section id="patients-with-aml-rarely-discuss-their-end-of-life-eol-care-preferences" class="level3" data-number="9.1.4"><h3 data-number="9.1.4" class="anchored" data-anchor-id="patients-with-aml-rarely-discuss-their-end-of-life-eol-care-preferences">
<span class="header-section-number">9.1.4</span> Patients with AML rarely discuss their end-of-life (EOL) care preferences</h3>
<p>Due to the chance of cure even after multiple therapies, oncology clinicians often defer engaging in conversations with patients with AML about their EOL care preferences <span class="citation" data-cites="eljawahri2020palliative">(<a href="70_references.html#ref-eljawahri2020palliative" role="doc-biblioref">A. El-Jawahri et al. 2020</a>)</span>. As the majority of these patients die, it is imperative that oncology clinicians elicit their goals and help them make decisions about their EOL care. Unfortunately, studies show that patients with AML do not engage in timely discussions with their clinicians about their care preferences and consequently receive aggressive care at the EOL <span class="citation" data-cites="ghodraty2015coping eljawahri2015utilization leblanc2019paradigms leblanc2018transfusion hui2014quality eljawahri2015utilization2 eljawahri2020palliative bosshard2018economic klepin2014aml">(<a href="70_references.html#ref-ghodraty2015coping" role="doc-biblioref">V. Ghodraty-Jabloo et al. 2015</a>; <a href="70_references.html#ref-eljawahri2015utilization" role="doc-biblioref">A. R. El-Jawahri et al. 2015b</a>; <a href="70_references.html#ref-leblanc2019paradigms" role="doc-biblioref">T. W. LeBlanc and Erba 2019</a>; <a href="70_references.html#ref-leblanc2018transfusion" role="doc-biblioref">T. W. LeBlanc, Egan, and Olszewski 2018</a>; <a href="70_references.html#ref-hui2014quality" role="doc-biblioref">D. Hui et al. 2014</a>; <a href="70_references.html#ref-eljawahri2015utilization2" role="doc-biblioref">A. A. El-Jawahri et al. 2015</a>; <a href="70_references.html#ref-eljawahri2020palliative" role="doc-biblioref">A. El-Jawahri et al. 2020</a>; <a href="70_references.html#ref-bosshard2018economic" role="doc-biblioref">Bosshard et al. 2018</a>; <a href="70_references.html#ref-klepin2014aml" role="doc-biblioref">Klepin, Rao, and Pardee 2014</a>)</span>. Specifically, while many patients with cancer express a preference to die at home and minimize time in the hospital, 80% of patients with AML are hospitalized in the last month of life, with 50% dying in the hospital. Over half receive chemotherapy in the last month of life and 30% die in the intensive care unit (ICU) <span class="citation" data-cites="ghodraty2015coping eljawahri2015utilization leblanc2019paradigms leblanc2018transfusion hui2014quality eljawahri2015utilization2 eljawahri2020palliative bosshard2018economic klepin2014aml">(<a href="70_references.html#ref-ghodraty2015coping" role="doc-biblioref">V. Ghodraty-Jabloo et al. 2015</a>; <a href="70_references.html#ref-eljawahri2015utilization" role="doc-biblioref">A. R. El-Jawahri et al. 2015b</a>; <a href="70_references.html#ref-leblanc2019paradigms" role="doc-biblioref">T. W. LeBlanc and Erba 2019</a>; <a href="70_references.html#ref-leblanc2018transfusion" role="doc-biblioref">T. W. LeBlanc, Egan, and Olszewski 2018</a>; <a href="70_references.html#ref-hui2014quality" role="doc-biblioref">D. Hui et al. 2014</a>; <a href="70_references.html#ref-eljawahri2015utilization2" role="doc-biblioref">A. A. El-Jawahri et al. 2015</a>; <a href="70_references.html#ref-eljawahri2020palliative" role="doc-biblioref">A. El-Jawahri et al. 2020</a>; <a href="70_references.html#ref-bosshard2018economic" role="doc-biblioref">Bosshard et al. 2018</a>; <a href="70_references.html#ref-klepin2014aml" role="doc-biblioref">Klepin, Rao, and Pardee 2014</a>)</span>. Evidence-based interventions are needed to enhance patient–clinician communication and optimize EOL care for patients with AML.</p>
</section><section id="caregivers-of-patients-with-aml-experience-tremendous-burden-and-distress" class="level3" data-number="9.1.5"><h3 data-number="9.1.5" class="anchored" data-anchor-id="caregivers-of-patients-with-aml-experience-tremendous-burden-and-distress">
<span class="header-section-number">9.1.5</span> Caregivers of patients with AML experience tremendous burden and distress</h3>
<p>The family and close friends (“caregivers”) of patients with AML play a critical role in their care, but also experience distress as they face the shock of the patient’s diagnosis and cope with uncertainty <span class="citation" data-cites="eljawahri2019quality jia2015ptsdcaregivers gemmill2011caregivers fife2009adaptation">(<a href="70_references.html#ref-eljawahri2019quality" role="doc-biblioref">A. El-Jawahri et al. 2019</a>; <a href="70_references.html#ref-jia2015ptsdcaregivers" role="doc-biblioref">Jia et al. 2015</a>; <a href="70_references.html#ref-gemmill2011caregivers" role="doc-biblioref">Gemmill et al. 2011</a>; <a href="70_references.html#ref-fife2009adaptation" role="doc-biblioref">Fife et al. 2009</a>)</span>. During the patient’s hospitalization for treatment, caregivers report a marked decline in their QOL and mood as they witness the patient struggle with side effects <span class="citation" data-cites="eljawahri2019quality">(<a href="70_references.html#ref-eljawahri2019quality" role="doc-biblioref">A. El-Jawahri et al. 2019</a>)</span>. After the patient is discharged from the hospital, the caregiver helps manage the patient’s symptoms, attends multiple oncology appointments, coordinates medical care, and prepares for subsequent hospitalizations <span class="citation" data-cites="grover2019caregiver">(<a href="70_references.html#ref-grover2019caregiver" role="doc-biblioref">Grover et al. 2019</a>)</span>. Caregivers experience the highest burden and psychological distress when caring for patients with AML near the EOL <span class="citation" data-cites="grover2019caregiver gerlach2019challenges">(<a href="70_references.html#ref-grover2019caregiver" role="doc-biblioref">Grover et al. 2019</a>; <a href="70_references.html#ref-gerlach2019challenges" role="doc-biblioref">Gerlach, Alt-Epping, and Oechsle 2019</a>)</span>. Not surprisingly, caregivers of patients with AML have disruptions in their professional and personal lives. Thus, caregivers of patients with AML would benefit from support as they navigate the patient’s illness.</p>
</section><section id="specialty-palliative-care-improves-outcomes-for-patients-and-their-caregivers" class="level3" data-number="9.1.6"><h3 data-number="9.1.6" class="anchored" data-anchor-id="specialty-palliative-care-improves-outcomes-for-patients-and-their-caregivers">
<span class="header-section-number">9.1.6</span> Specialty palliative care improves outcomes for patients and their caregivers</h3>
<p>A growing body of evidence has demonstrated the essential role of specialty palliative care (PC) clinicians in the care of patients with advanced solid tumors <span class="citation" data-cites="temel2010early temel2017integrated bakitas2009enable2 bakitas2015enable3 zimmermann2014cluster">(<a href="70_references.html#ref-temel2010early" role="doc-biblioref">Temel et al. 2010</a>, <a href="70_references.html#ref-temel2017integrated" role="doc-biblioref">2017</a>; <a href="70_references.html#ref-bakitas2009enable2" role="doc-biblioref">M. Bakitas et al. 2009</a>; <a href="70_references.html#ref-bakitas2015enable3" role="doc-biblioref">M. A. Bakitas et al. 2015</a>; <a href="70_references.html#ref-zimmermann2014cluster" role="doc-biblioref">Zimmermann et al. 2014</a>)</span>. Integrating PC with oncology care from the time of diagnosis for patients with advanced solid tumors improves patients’ QOL, psychological health, and EOL care <span class="citation" data-cites="temel2010early temel2017integrated bakitas2009enable2 bakitas2015enable3 zimmermann2014cluster">(<a href="70_references.html#ref-temel2010early" role="doc-biblioref">Temel et al. 2010</a>, <a href="70_references.html#ref-temel2017integrated" role="doc-biblioref">2017</a>; <a href="70_references.html#ref-bakitas2009enable2" role="doc-biblioref">M. Bakitas et al. 2009</a>; <a href="70_references.html#ref-bakitas2015enable3" role="doc-biblioref">M. A. Bakitas et al. 2015</a>; <a href="70_references.html#ref-zimmermann2014cluster" role="doc-biblioref">Zimmermann et al. 2014</a>)</span>. Emerging data have similarly shown the benefits of specialty PC for patients with hematologic malignancies <span class="citation" data-cites="ElJawahri2016 ElJawahri2017 ElJawahri2021">(<a href="70_references.html#ref-ElJawahri2016" role="doc-biblioref">Areej R. El-Jawahri et al. 2016</a>, <a href="70_references.html#ref-ElJawahri2017" role="doc-biblioref">2017</a>; <a href="70_references.html#ref-ElJawahri2021" role="doc-biblioref">Areej El-Jawahri et al. 2021</a>)</span>. We recently completed a multi-site randomized trial of specialty PC versus usual care in hospitalized patients with AML <span class="citation" data-cites="ElJawahri2021">(<a href="70_references.html#ref-ElJawahri2021" role="doc-biblioref">Areej El-Jawahri et al. 2021</a>)</span>. Patients assigned to specialty PC met with a PC clinician at least twice weekly during their hospitalization for chemotherapy and subsequent hospitalizations up to one year. Specialty PC improved patients’ QOL, depression and anxiety symptoms, as well as post-traumatic stress symptoms <span class="citation" data-cites="ElJawahri2021">(<a href="70_references.html#ref-ElJawahri2021" role="doc-biblioref">Areej El-Jawahri et al. 2021</a>)</span>. Importantly, specialty PC led to clinically meaningful and sustained improvements in patients’ QOL and psychological distress for six months after initiating chemotherapy <span class="citation" data-cites="ElJawahri2021">(<a href="70_references.html#ref-ElJawahri2021" role="doc-biblioref">Areej El-Jawahri et al. 2021</a>)</span>. Patients receiving specialty PC were also more likely to discuss their EOL care preferences and less likely to receive chemotherapy in the last month of life <span class="citation" data-cites="ElJawahri2021">(<a href="70_references.html#ref-ElJawahri2021" role="doc-biblioref">Areej El-Jawahri et al. 2021</a>)</span>. Thus, involvement of specialty PC improves the experience and outcomes of patients with serious cancer and their caregivers.</p>
</section><section id="specialty-pc-is-not-an-accessible-or-scalable-care-model" class="level3" data-number="9.1.7"><h3 data-number="9.1.7" class="anchored" data-anchor-id="specialty-pc-is-not-an-accessible-or-scalable-care-model">
<span class="header-section-number">9.1.7</span> Specialty PC is not an accessible or scalable care model</h3>
<p>Despite the benefits of specialty PC for patients with cancer, it is not feasible to provide this care for all patients given the limited availability of trained PC clinicians <span class="citation" data-cites="Hui2010 Lupu2010 Blackhall2016">(<a href="70_references.html#ref-Hui2010" role="doc-biblioref">David Hui et al. 2010</a>; <a href="70_references.html#ref-Lupu2010" role="doc-biblioref">Lupu, Hospice, and Force 2010</a>; <a href="70_references.html#ref-Blackhall2016" role="doc-biblioref">Blackhall et al. 2016</a>)</span>. Nearly half of National Cancer Institute-designated cancer centers do not have the specialty PC workforce to provide care for their patients with cancer <span class="citation" data-cites="Hui2010 Lupu2010 Blackhall2016">(<a href="70_references.html#ref-Hui2010" role="doc-biblioref">David Hui et al. 2010</a>; <a href="70_references.html#ref-Lupu2010" role="doc-biblioref">Lupu, Hospice, and Force 2010</a>; <a href="70_references.html#ref-Blackhall2016" role="doc-biblioref">Blackhall et al. 2016</a>)</span>. Due to these workforce shortages, most specialty PC is triaged to provide care for patients with incurable cancer at the EOL. Thus, despite the growing evidence base, substantial challenges limit the scalability and dissemination of this care model, especially in caring for patients with hematologic malignancies <span class="citation" data-cites="eljawahri2020palliative LeBlanc2015">(<a href="70_references.html#ref-eljawahri2020palliative" role="doc-biblioref">A. El-Jawahri et al. 2020</a>; <a href="70_references.html#ref-LeBlanc2015" role="doc-biblioref">Thomas W. LeBlanc and El-Jawahri 2015</a>)</span>. Moreover, oncology clinicians caring for patients with hematologic malignancies rarely consult specialty PC as they view providing PC within their scope of practice <span class="citation" data-cites="eljawahri2020palliative LeBlanc2018 ElJawahri2018 Hui2015">(<a href="70_references.html#ref-eljawahri2020palliative" role="doc-biblioref">A. El-Jawahri et al. 2020</a>; <a href="70_references.html#ref-LeBlanc2018" role="doc-biblioref">Thomas W. LeBlanc and El-Jawahri 2018</a>; <a href="70_references.html#ref-ElJawahri2018" role="doc-biblioref">Areej El-Jawahri et al. 2018</a>; <a href="70_references.html#ref-Hui2015" role="doc-biblioref">David Hui et al. 2015</a>)</span>. Furthermore, given the complex chemotherapy regimens used to treat patients with AML and their side effects, oncology clinicians may be the ideal clinicians to address these needs <span class="citation" data-cites="eljawahri2020palliative LeBlanc2018 ElJawahri2018 Hui2015">(<a href="70_references.html#ref-eljawahri2020palliative" role="doc-biblioref">A. El-Jawahri et al. 2020</a>; <a href="70_references.html#ref-LeBlanc2018" role="doc-biblioref">Thomas W. LeBlanc and El-Jawahri 2018</a>; <a href="70_references.html#ref-ElJawahri2018" role="doc-biblioref">Areej El-Jawahri et al. 2018</a>; <a href="70_references.html#ref-Hui2015" role="doc-biblioref">David Hui et al. 2015</a>)</span>.</p>
</section><section id="primary-pc-may-be-an-alternative-care-model-to-specialty-pc" class="level3" data-number="9.1.8"><h3 data-number="9.1.8" class="anchored" data-anchor-id="primary-pc-may-be-an-alternative-care-model-to-specialty-pc">
<span class="header-section-number">9.1.8</span> Primary PC may be an alternative care model to specialty PC</h3>
<p>Training oncology clinicians to incorporate PC skills into their care practice (i.e., “primary PC”) is an alternative strategy to having specialty trained PC clinicians care for all patients with cancer. Recent studies have shown that primary PC interventions in which oncology clinicians are trained to address patient’s symptoms and engage in serious illness conversations are feasible, acceptable, and improve patient outcomes <span class="citation" data-cites="Bernacki2019 Paladino2019">(<a href="70_references.html#ref-Bernacki2019" role="doc-biblioref">Bernacki et al. 2019</a>; <a href="70_references.html#ref-Paladino2019" role="doc-biblioref">Paladino et al. 2019</a>)</span>. These interventions have been shown to increase oncology clinicians’ knowledge about symptom assessment and management, as well as their comfort managing psychological distress <span class="citation" data-cites="Epstein2017 Reddy2019 Schenker2015">(<a href="70_references.html#ref-Epstein2017" role="doc-biblioref">Epstein et al. 2017</a>; <a href="70_references.html#ref-Reddy2019" role="doc-biblioref">Reddy et al. 2019</a>; <a href="70_references.html#ref-Schenker2015" role="doc-biblioref">Schenker et al. 2015</a>)</span>. In a cluster randomized trial in which oncology clinicians were trained in serious illness communication, patients receiving primary PC were more likely to have documented EOL discussions and reported lower anxiety and depression symptoms <span class="citation" data-cites="Bernacki2019 Paladino2019">(<a href="70_references.html#ref-Bernacki2019" role="doc-biblioref">Bernacki et al. 2019</a>; <a href="70_references.html#ref-Paladino2019" role="doc-biblioref">Paladino et al. 2019</a>)</span>. While these primary PC studies are promising, it remains unknown how primary PC compares with specialty PC for improving QOL and EOL care for patients with cancer <span class="citation" data-cites="eljawahri2020palliative Kavalieratos2016">(<a href="70_references.html#ref-eljawahri2020palliative" role="doc-biblioref">A. El-Jawahri et al. 2020</a>; <a href="70_references.html#ref-Kavalieratos2016" role="doc-biblioref">Kavalieratos et al. 2016</a>)</span>. Recent systematic reviews highlight the need for comparative effectiveness trials of primary versus specialty PC, to determine how to best meet the needs of patients with serious cancers, and especially those with hematologic malignancies <span class="citation" data-cites="eljawahri2020palliative Kavalieratos2016">(<a href="70_references.html#ref-eljawahri2020palliative" role="doc-biblioref">A. El-Jawahri et al. 2020</a>; <a href="70_references.html#ref-Kavalieratos2016" role="doc-biblioref">Kavalieratos et al. 2016</a>)</span>.</p>
</section></section><section id="sec-resources" class="level2" data-number="9.2"><h2 data-number="9.2" class="anchored" data-anchor-id="sec-resources">
<span class="header-section-number">9.2</span> Resources Available</h2>
<section id="team-qualifications-and-oversight" class="level3" data-number="9.2.1"><h3 data-number="9.2.1" class="anchored" data-anchor-id="team-qualifications-and-oversight">
<span class="header-section-number">9.2.1</span> Team Qualifications and Oversight</h3>
<p>Due to the size and scope of this award, we have chosen a leadership plan with dual study PIs (Drs. Areej El-Jawahri and Jennifer Temel). The dual PIs have a long-standing history of collaboration with over 20 funded research projects, and led the specialty PC trial in leukemia, which serves as the preliminary data for the current project. The dual PIs pre-existing relationship, including a history of successful collaborations on grant applications and manuscripts in high tier medical journals, and complimentary experience conducing PC trials, will ensure they provide effective leadership of this study. The University of Colorado Data, Informatics, and Statistics Core will serve as the DCC. Dr.&nbsp;Colborn will provide independent leadership of the DCC and have autonomy over data integrity, data quality, and data analysis during both the study phases.. Prior studies have highlighted the unique challenges of conducting PC research trials with adequate methodological oversight and appropriate data analytical approach. Specifically, given their experience with PC research methodology, our DCC possess the necessary expertise to: - 1) ensure adequate oversight of data collection procedures for participant-reported outcomes - 2) address challenges of attrition and missing data due to death in PC research - 3) implement statistical methods to address missing data - 4) measure PC intervention fidelity. Furthermore, the DCC investigative team has substantial expertise in serving as the DCC for multiple large-scale multi-site projects.</p>
</section><section id="other-resources" class="level3" data-number="9.2.2"><h3 data-number="9.2.2" class="anchored" data-anchor-id="other-resources">
<span class="header-section-number">9.2.2</span> Other Resources</h3>
<p>We solicited participating sites through The Palliative Care Research Cooperative (PCRC) with medium to large leukemia practices to ensure that each site would see a minimum of 50 new patients with AML per year. We also chose sites that have an inpatient specialty PC practice to accommodate patients who are randomized to receiving specialty PC. Prior to submitting this project, we conducted interviews with 35 sites and chose 20 sites with appropriate infrastructure to conduct the study. As many of these sites are tertiary care centers, we estimate that 15% of new patients will be second-opinion consultations only and therefore ineligible. We estimate that each site will have a minimum of 40 eligible patients per year. At MGH, we have enrolled 70% of eligible patients with AML in our prior PC trials. Since the proposed study is a cluster randomized trial, we anticipate that enrollment rates will be higher than prior studies, as patients are not being randomized. Nonetheless, we conservatively estimate that at least 60% of eligible patients will enroll in the study. In our prior studies, 60% of patients who enrolled had a caregiver who was willing to participate, so we conservatively estimate caregiver enrollment rates of approximately 50%. Therefore, we are confident in our ability to achieve our proposed enrollment goals for patients and caregivers.</p>


<!-- -->

<div id="refs" class="references csl-bib-body hanging-indent" role="doc-bibliography" style="display: none">
<div id="ref-alibhai2015quality" class="csl-entry" role="doc-biblioentry">
Alibhai, S. M., H. Breunis, N. Timilshina, et al. 2015. <span>“Quality of Life and Physical Function in Adults Treated with Intensive Chemotherapy for Acute Myeloid Leukemia Improve over Time Independent of Age.”</span> <em>Journal of Geriatric Oncology</em> 6: 262–71.
</div>
<div id="ref-alibhai2007impact" class="csl-entry" role="doc-biblioentry">
Alibhai, S. M., M. Leach, H. Kermalli, et al. 2007. <span>“The Impact of Acute Myeloid Leukemia and Its Treatment on Quality of Life and Functional Status in Older Adults.”</span> <em>Critical Reviews in Oncology/Hematology</em> 64: 19–30.
</div>
<div id="ref-bakitas2015enable3" class="csl-entry" role="doc-biblioentry">
Bakitas, M. A., T. D. Tosteson, Z. Li, et al. 2015. <span>“Early Versus Delayed Initiation of Concurrent Palliative Oncology Care: Patient Outcomes in the ENABLE III Randomized Controlled Trial.”</span> <em>Journal of Clinical Oncology</em> 33: 1438–45.
</div>
<div id="ref-bakitas2009enable2" class="csl-entry" role="doc-biblioentry">
Bakitas, M., K. D. Lyons, M. T. Hegel, et al. 2009. <span>“Effects of a Palliative Care Intervention on Clinical Outcomes in Patients with Advanced Cancer: The Project ENABLE II Randomized Controlled Trial.”</span> <em>JAMA</em> 302: 741–49.
</div>
<div id="ref-Bernacki2019" class="csl-entry" role="doc-biblioentry">
Bernacki, Rachelle, Joanna Paladino, Bridget A. Neville, et al. 2019. <span>“Effect of the Serious Illness Care Program in Outpatient Oncology: A Cluster Randomized Clinical Trial.”</span> <em>JAMA Internal Medicine</em> 179: 751–59.
</div>
<div id="ref-Blackhall2016" class="csl-entry" role="doc-biblioentry">
Blackhall, Lesley J., Patrick Read, George Stukenborg, and et al. 2016. <span>“CARE Track for Advanced Cancer: Impact and Timing of an Outpatient Palliative Care Clinic.”</span> <em>Journal of Palliative Medicine</em> 19 (1): 57–63.
</div>
<div id="ref-bosshard2018economic" class="csl-entry" role="doc-biblioentry">
Bosshard, R., K. O’Reilly, S. Ralston, et al. 2018. <span>“Systematic Reviews of Economic Burden and Health-Related Quality of Life in Patients with Acute Myeloid Leukemia.”</span> <em>Cancer Treatment Reviews</em> 69: 224–32.
</div>
<div id="ref-burnett2010attempts" class="csl-entry" role="doc-biblioentry">
Burnett, A. K., R. K. Hills, D. W. Milligan, et al. 2010. <span>“Attempts to Optimize Induction and Consolidation Treatment in Acute Myeloid Leukemia: Results of the MRC Aml12 Trial.”</span> <em>Journal of Clinical Oncology</em> 28: 586–95.
</div>
<div id="ref-eljawahri2015utilization2" class="csl-entry" role="doc-biblioentry">
El-Jawahri, A. A., G. A. Steensma, D. P. LeBlanc, T. W. Fathi, A. T. Graubert, T. DeAngelo, D. J. Wadleigh, et al. 2015. <span>“Health Care Utilization and End of Life Care for Older Patients with Acute Myeloid Leukemia.”</span> <em>Cancer</em>.
</div>
<div id="ref-eljawahri2015health" class="csl-entry" role="doc-biblioentry">
El-Jawahri, A. R., G. A. Abel, D. P. Steensma, et al. 2015a. <span>“Health Care Utilization and End-of-Life Care for Older Patients with Acute Myeloid Leukemia.”</span> <em>Cancer</em> 121: 2840–48.
</div>
<div id="ref-eljawahri2015utilization" class="csl-entry" role="doc-biblioentry">
———, et al. 2015b. <span>“Health Care Utilization and End-of-Life Care for Older Patients with Acute Myeloid Leukemia.”</span> <em>Cancer</em>.
</div>
<div id="ref-eljawahri2019quality" class="csl-entry" role="doc-biblioentry">
El-Jawahri, A., G. A. Abel, L. Traeger, et al. 2019. <span>“Quality of Life and Mood of Older Patients with Acute Myeloid Leukemia (AML) Receiving Intensive and Non-Intensive Chemotherapy.”</span> <em>Leukemia</em> 33: 2393–2402.
</div>
<div id="ref-eljawahri2020palliative" class="csl-entry" role="doc-biblioentry">
El-Jawahri, A., A. M. Nelson, T. F. Gray, et al. 2020. <span>“Palliative and End-of-Life Care for Patients with Hematologic Malignancies.”</span> <em>Journal of Clinical Oncology</em> 38: 944–53.
</div>
<div id="ref-eljawahri2018discordance" class="csl-entry" role="doc-biblioentry">
El-Jawahri, A., M. Nelson-Lowe, H. VanDusen, et al. 2018. <span>“Patient-Clinician Discordance in Perceptions of Treatment Risks and Benefits in Older Patients with Acute Myeloid Leukemia.”</span> <em>The Oncologist</em>.
</div>
<div id="ref-ElJawahri2016" class="csl-entry" role="doc-biblioentry">
El-Jawahri, Areej R., Thomas LeBlanc, Hannah VanDusen, and et al. 2016. <span>“Effect of Inpatient Palliative Care on Quality of Life 2 Weeks After Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial.”</span> <em>JAMA</em> 316 (20): 2094–2103.
</div>
<div id="ref-ElJawahri2017" class="csl-entry" role="doc-biblioentry">
El-Jawahri, Areej R., Leigh N. Traeger, Jennifer A. Greer, and et al. 2017. <span>“Effect of Inpatient Palliative Care During Hematopoietic Stem-Cell Transplant on Psychological Distress 6 Months After Transplant: Results of a Randomized Clinical Trial.”</span> <em>Journal of Clinical Oncology</em> 35 (32): 3714–21.
</div>
<div id="ref-ElJawahri2018" class="csl-entry" role="doc-biblioentry">
El-Jawahri, Areej, Thomas W. LeBlanc, Linda J. Burns, and et al. 2018. <span>“What Do Transplant Physicians Think about Palliative Care? A National Survey Study.”</span> <em>Cancer</em> 124 (21): 4556–66.
</div>
<div id="ref-ElJawahri2021" class="csl-entry" role="doc-biblioentry">
El-Jawahri, Areej, Thomas W. LeBlanc, Alison Kavanaugh, and et al. 2021. <span>“Effectiveness of Integrated Palliative and Oncology Care for Patients with Acute Myeloid Leukemia: A Randomized Clinical Trial.”</span> <em>JAMA Oncology</em> 7 (2): 238–45.
</div>
<div id="ref-Epstein2017" class="csl-entry" role="doc-biblioentry">
Epstein, Ronald M., Paul R. Duberstein, J. J. Fenton, et al. 2017. <span>“Effect of a Patient-Centered Communication Intervention on Oncologist-Patient Communication, Quality of Life, and Health Care Utilization in Advanced Cancer: The VOICE Randomized Clinical Trial.”</span> <em>JAMA Oncology</em> 3: 92–100.
</div>
<div id="ref-farsi2012coping" class="csl-entry" role="doc-biblioentry">
Farsi, Z., N. D. Nayeri, and R. Negarandeh. 2012. <span>“The Coping Process in Adults with Acute Leukemia Undergoing Hematopoietic Stem Cell Transplantation.”</span> <em>Journal of Nursing Research</em> 20: 99–109.
</div>
<div id="ref-fife2009adaptation" class="csl-entry" role="doc-biblioentry">
Fife, B. L., P. O. Monahan, R. Abonour, et al. 2009. <span>“Adaptation of Family Caregivers During the Acute Phase of Adult BMT.”</span> <em>Bone Marrow Transplantation</em> 43: 959–66.
</div>
<div id="ref-ganzel2018poor" class="csl-entry" role="doc-biblioentry">
Ganzel, C., Z. Sun, L. D. Cripe, et al. 2018. <span>“Very Poor Long-Term Survival in Past and More Recent Studies for Relapsed AML Patients: The ECOG-ACRIN Experience.”</span> <em>American Journal of Hematology</em>.
</div>
<div id="ref-gemmill2011caregivers" class="csl-entry" role="doc-biblioentry">
Gemmill, R., L. Cooke, A. C. Williams, et al. 2011. <span>“Informal Caregivers of Hematopoietic Cell Transplant Patients: A Review and Recommendations for Interventions and Research.”</span> <em>Cancer Nursing</em> 34: E13–21.
</div>
<div id="ref-gerlach2019challenges" class="csl-entry" role="doc-biblioentry">
Gerlach, C., B. Alt-Epping, and K. Oechsle. 2019. <span>“Specific Challenges in End-of-Life Care for Patients with Hematological Malignancies.”</span> <em>Current Opinion in Supportive and Palliative Care</em> 13: 369–79.
</div>
<div id="ref-gheihman2015depression" class="csl-entry" role="doc-biblioentry">
Gheihman, G., C. Zimmermann, A. Deckert, et al. 2015. <span>“Depression and Hopelessness in Patients with Acute Leukemia: The Psychological Impact of an Acute and Life-Threatening Disorder.”</span> <em>Psychooncology</em>.
</div>
<div id="ref-ghodraty2015coping" class="csl-entry" role="doc-biblioentry">
Ghodraty-Jabloo, V., S. M. Alibhai, H. Breunis, et al. 2015. <span>“Keep Your Mind Off Negative Things: Coping with Long-Term Effects of Acute Myeloid Leukemia (AML).”</span> <em>Supportive Care in Cancer</em>.
</div>
<div id="ref-ghodraty2015oneday" class="csl-entry" role="doc-biblioentry">
Ghodraty-Jabloo, Vida, Shabbir MH Alibhai, Henriette Breunis, and Martine TE Puts. 2015. <span>“One Day at a Time: Improving the Patient Experience During and After Intensive Chemotherapy for Younger and Older AML Patients.”</span> <em>Leukemia Research</em> 39 (2): 192–97.
</div>
<div id="ref-grover2019caregiver" class="csl-entry" role="doc-biblioentry">
Grover, S., K. Rina, P. Malhotra, et al. 2019. <span>“Caregiver Burden in the Patients of Acute Myeloblastic Leukemia.”</span> <em>Indian Journal of Hematology and Blood Transfusion</em> 35: 437–45.
</div>
<div id="ref-Hui2010" class="csl-entry" role="doc-biblioentry">
Hui, David, Ahmed Elsayem, Eduardo Bruera, and et al. 2010. <span>“Availability and Integration of Palliative Care at US Cancer Centers.”</span> <em>JAMA</em> 303 (11): 1054–61.
</div>
<div id="ref-Hui2015" class="csl-entry" role="doc-biblioentry">
Hui, David, Matthew Park, Di Zhang, and et al. 2015. <span>“Attitudes and Beliefs Toward Supportive and Palliative Care Referral Among Hematologic and Solid Tumor Oncology Specialists.”</span> <em>The Oncologist</em> 20 (11): 1326–32.
</div>
<div id="ref-hui2014quality" class="csl-entry" role="doc-biblioentry">
Hui, D., N. Didwaniya, M. Vidal, et al. 2014. <span>“Quality of End-of-Life Care in Patients with Hematologic Malignancies: A Retrospective Cohort Study.”</span> <em>Cancer</em> 120: 1572–78.
</div>
<div id="ref-jacobsen2002predictors" class="csl-entry" role="doc-biblioentry">
Jacobsen, P. B., I. J. Sadler, M. Booth-Jones, et al. 2002. <span>“Predictors of Posttraumatic Stress Disorder Symptomatology Following Bone Marrow Transplantation for Cancer.”</span> <em>Journal of Consulting and Clinical Psychology</em> 70: 235–40.
</div>
<div id="ref-jacobsen1998ptsd" class="csl-entry" role="doc-biblioentry">
Jacobsen, P. B., M. R. Widows, D. M. Hann, et al. 1998. <span>“Posttraumatic Stress Disorder Symptoms After Bone Marrow Transplantation for Breast Cancer.”</span> <em>Psychosomatic Medicine</em> 60: 366–71.
</div>
<div id="ref-jia2015ptsdcaregivers" class="csl-entry" role="doc-biblioentry">
Jia, M., J. Li, C. Chen, et al. 2015. <span>“Post-Traumatic Stress Disorder Symptoms in Family Caregivers of Adult Patients with Acute Leukemia from a Dyadic Perspective.”</span> <em>Psychooncology</em> 24: 1754–60.
</div>
<div id="ref-Kavalieratos2016" class="csl-entry" role="doc-biblioentry">
Kavalieratos, Dimitrios, Jane Corbelli, D. Zhang, et al. 2016. <span>“Association Between Palliative Care and Patient and Caregiver Outcomes: A Systematic Review and Meta-Analysis.”</span> <em>JAMA</em> 316: 2104–14.
</div>
<div id="ref-klepin2014aml" class="csl-entry" role="doc-biblioentry">
Klepin, H. D., A. V. Rao, and T. S. Pardee. 2014. <span>“Acute Myeloid Leukemia and Myelodysplastic Syndromes in Older Adults.”</span> <em>Journal of Clinical Oncology</em> 32: 2541–52.
</div>
<div id="ref-leblanc2018transfusion" class="csl-entry" role="doc-biblioentry">
LeBlanc, T. W., P. C. Egan, and A. J. Olszewski. 2018. <span>“Transfusion Dependence, Use of Hospice Services, and Quality of End-of-Life Care in Leukemia.”</span> <em>Blood</em> 132: 717–26.
</div>
<div id="ref-leblanc2019paradigms" class="csl-entry" role="doc-biblioentry">
LeBlanc, T. W., and H. P. Erba. 2019. <span>“Shifting Paradigms in the Treatment of Older Adults with AML.”</span> <em>Seminars in Hematology</em> 56: 110–17.
</div>
<div id="ref-LeBlanc2015" class="csl-entry" role="doc-biblioentry">
LeBlanc, Thomas W., and Areej El-Jawahri. 2015. <span>“When and Why Should Patients with Hematologic Malignancies See a Palliative Care Specialist?”</span> <em>Hematology. American Society of Hematology. Education Program</em> 2015 (1): 471–78.
</div>
<div id="ref-LeBlanc2018" class="csl-entry" role="doc-biblioentry">
———. 2018. <span>“Hemato-Oncology and Palliative Care Teams: Is It Time for an Integrated Approach to Patient Care?”</span> <em>Current Opinion in Supportive and Palliative Care</em> 12 (4): 530–37.
</div>
<div id="ref-loh2019health" class="csl-entry" role="doc-biblioentry">
Loh, K. P., M. Abdallah, A. J. Kumar, et al. 2019. <span>“Health-Related Quality of Life and Treatment of Older Adults with Acute Myeloid Leukemia: A Young International Society of Geriatric Oncology Review Paper.”</span> <em>Current Hematologic Malignancy Reports</em> 14: 523–35.
</div>
<div id="ref-Lupu2010" class="csl-entry" role="doc-biblioentry">
Lupu, Diane, American Academy of Hospice, and Palliative Medicine Workforce Task Force. 2010. <span>“Estimate of Current Hospice and Palliative Medicine Physician Workforce Shortage.”</span> <em>Journal of Pain and Symptom Management</em> 40 (6): 899–911.
</div>
<div id="ref-mundy2000ptsd" class="csl-entry" role="doc-biblioentry">
Mundy, E. A., E. B. Blanchard, E. Cirenza, et al. 2000. <span>“Posttraumatic Stress Disorder in Breast Cancer Patients Following Autologous Bone Marrow Transplantation or Conventional Cancer Treatments.”</span> <em>Behaviour Research and Therapy</em> 38: 1015–27.
</div>
<div id="ref-nissim2014bearings" class="csl-entry" role="doc-biblioentry">
Nissim, R., G. Rodin, A. Schimmer, et al. 2014. <span>“Finding New Bearings: A Qualitative Study on the Transition from Inpatient to Ambulatory Care of Patients with Acute Myeloid Leukemia.”</span> <em>Supportive Care in Cancer</em> 22: 2435–43.
</div>
<div id="ref-nissim2013abducted" class="csl-entry" role="doc-biblioentry">
Nissim, R., C. Zimmermann, M. Minden, et al. 2013. <span>“Abducted by the Illness: A Qualitative Study of Traumatic Stress in Individuals with Acute Leukemia.”</span> <em>Leukemia Research</em> 37: 496–502.
</div>
<div id="ref-Paladino2019" class="csl-entry" role="doc-biblioentry">
Paladino, Joanna, Rachelle Bernacki, Bridget A. Neville, et al. 2019. <span>“Evaluating an Intervention to Improve Communication Between Oncology Clinicians and Patients with Life-Limiting Cancer: A Cluster Randomized Clinical Trial of the Serious Illness Care Program.”</span> <em>JAMA Oncology</em> 5: 801–9.
</div>
<div id="ref-papadopoulou2013experience" class="csl-entry" role="doc-biblioentry">
Papadopoulou, C., B. Johnston, and M. Themessl-Huber. 2013. <span>“The Experience of Acute Leukaemia in Adult Patients: A Qualitative Thematic Synthesis.”</span> <em>European Journal of Oncology Nursing</em> 17: 640–48.
</div>
<div id="ref-Reddy2019" class="csl-entry" role="doc-biblioentry">
Reddy, S. K., K. Tanco, S. Yennu, et al. 2019. <span>“Integration of a Mandatory Palliative Care Education into Hematology-Oncology Fellowship Training in a Comprehensive Cancer Center: A Survey of Hematology Oncology Fellows.”</span> <em>Journal of Oncology Practice</em> 15: e934–41.
</div>
<div id="ref-rodin2013traumatic" class="csl-entry" role="doc-biblioentry">
Rodin, G., D. Yuen, A. Mischitelle, et al. 2013. <span>“Traumatic Stress in Acute Leukemia.”</span> <em>Psycho-Oncology</em> 22: 299–307.
</div>
<div id="ref-Schenker2015" class="csl-entry" role="doc-biblioentry">
Schenker, Yael, D. White, M. Rosenzweig, et al. 2015. <span>“Care Management by Oncology Nurses to Address Palliative Care Needs: A Pilot Trial to Assess Feasibility, Acceptability, and Perceived Effectiveness of the CONNECT Intervention.”</span> <em>Journal of Palliative Medicine</em> 18: 232–40.
</div>
<div id="ref-schlenk2017relapsed" class="csl-entry" role="doc-biblioentry">
Schlenk, R. F., C. Muller-Tidow, A. Benner, et al. 2017. <span>“Relapsed/Refractory Acute Myeloid Leukemia: Any Progress?”</span> <em>Current Opinion in Oncology</em> 29: 467–73.
</div>
<div id="ref-smith1999ptsd" class="csl-entry" role="doc-biblioentry">
Smith, M. Y., W. Redd, K. DuHamel, et al. 1999. <span>“Validation of the PTSD Checklist-Civilian Version in Survivors of Bone Marrow Transplantation.”</span> <em>Journal of Traumatic Stress</em> 12: 485–99.
</div>
<div id="ref-temel2017integrated" class="csl-entry" role="doc-biblioentry">
Temel, J. S., J. A. Greer, A. El-Jawahri, et al. 2017. <span>“Effects of Early Integrated Palliative Care in Patients with Lung and GI Cancer: A Randomized Clinical Trial.”</span> <em>Journal of Clinical Oncology</em> 35: 834–41.
</div>
<div id="ref-temel2010early" class="csl-entry" role="doc-biblioentry">
Temel, J. S., J. A. Greer, A. Muzikansky, et al. 2010. <span>“Early Palliative Care for Patients with Metastatic Non-Small-Cell Lung Cancer.”</span> <em>New England Journal of Medicine</em> 363: 733–42.
</div>
<div id="ref-vey2020low" class="csl-entry" role="doc-biblioentry">
Vey, N. 2020. <span>“Low-Intensity Regimens Versus Standard-Intensity Induction Strategies in Acute Myeloid Leukemia.”</span> <em>Therapeutic Advances in Hematology</em> 11: 2040620720913010.
</div>
<div id="ref-walter2020selection" class="csl-entry" role="doc-biblioentry">
Walter, R. B., and E. H. Estey. 2020. <span>“Selection of Initial Therapy for Newly-Diagnosed Adult Acute Myeloid Leukemia: Limitations of Predictive Models.”</span> <em>Blood Reviews</em>, 100679.
</div>
<div id="ref-wiese2018unmet" class="csl-entry" role="doc-biblioentry">
Wiese, M., and N. Daver. 2018. <span>“Unmet Clinical Needs and Economic Burden of Disease in the Treatment Landscape of Acute Myeloid Leukemia.”</span> <em>American Journal of Managed Care</em> 24: S347–55.
</div>
<div id="ref-zimmermann2014cluster" class="csl-entry" role="doc-biblioentry">
Zimmermann, C., N. Swami, M. Krzyzanowska, et al. 2014. <span>“Early Palliative Care for Patients with Advanced Cancer: A Cluster-Randomised Controlled Trial.”</span> <em>Lancet</em> 383: 1721–30.
</div>
<div id="ref-zimmermann2013symptom" class="csl-entry" role="doc-biblioentry">
Zimmermann, C., D. Yuen, A. Mischitelle, et al. 2013. <span>“Symptom Burden and Supportive Care in Patients with Acute Leukemia.”</span> <em>Leukemia Research</em> 37: 731–36.
</div>
<div id="ref-zittoun1999assessment" class="csl-entry" role="doc-biblioentry">
Zittoun, R., S. Achard, and M. Ruszniewski. 1999. <span>“Assessment of Quality of Life During Intensive Chemotherapy or Bone Marrow Transplantation.”</span> <em>Psycho-Oncology</em> 8: 64–73.
</div>
</div>
</section></section></main><!-- /main --><script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const disableStylesheet = (stylesheets) => {
    for (let i=0; i < stylesheets.length; i++) {
      const stylesheet = stylesheets[i];
      stylesheet.rel = 'prefetch';
    }
  }
  const enableStylesheet = (stylesheets) => {
    for (let i=0; i < stylesheets.length; i++) {
      const stylesheet = stylesheets[i];
      stylesheet.rel = 'stylesheet';
    }
  }
  const manageTransitions = (selector, allowTransitions) => {
    const els = window.document.querySelectorAll(selector);
    for (let i=0; i < els.length; i++) {
      const el = els[i];
      if (allowTransitions) {
        el.classList.remove('notransition');
      } else {
        el.classList.add('notransition');
      }
    }
  }
  const toggleColorMode = (alternate) => {
    // Switch the stylesheets
    const alternateStylesheets = window.document.querySelectorAll('link.quarto-color-scheme.quarto-color-alternate');
    manageTransitions('#quarto-margin-sidebar .nav-link', false);
    if (alternate) {
      enableStylesheet(alternateStylesheets);
      for (const sheetNode of alternateStylesheets) {
        if (sheetNode.id === "quarto-bootstrap") {
          toggleBodyColorMode(sheetNode);
        }
      }
    } else {
      disableStylesheet(alternateStylesheets);
      toggleBodyColorPrimary();
    }
    manageTransitions('#quarto-margin-sidebar .nav-link', true);
    // Switch the toggles
    const toggles = window.document.querySelectorAll('.quarto-color-scheme-toggle');
    for (let i=0; i < toggles.length; i++) {
      const toggle = toggles[i];
      if (toggle) {
        if (alternate) {
          toggle.classList.add("alternate");     
        } else {
          toggle.classList.remove("alternate");
        }
      }
    }
  }
  const isFileUrl = () => { 
    return window.location.protocol === 'file:';
  }
  const hasAlternateSentinel = () => {  
    let styleSentinel = getColorSchemeSentinel();
    if (styleSentinel !== null) {
      return styleSentinel === "alternate";
    } else {
      return false;
    }
  }
  const setStyleSentinel = (alternate) => {
    const value = alternate ? "alternate" : "default";
    if (!isFileUrl()) {
      window.localStorage.setItem("quarto-color-scheme", value);
    } else {
      localAlternateSentinel = value;
    }
  }
  const getColorSchemeSentinel = () => {
    if (!isFileUrl()) {
      const storageValue = window.localStorage.getItem("quarto-color-scheme");
      return storageValue != null ? storageValue : localAlternateSentinel;
    } else {
      return localAlternateSentinel;
    }
  }
  let localAlternateSentinel = 'default';
  // Dark / light mode switch
  window.quartoToggleColorScheme = () => {
    // Read the current dark / light value 
    let toAlternate = !hasAlternateSentinel();
    toggleColorMode(toAlternate);
    setStyleSentinel(toAlternate);
  };
  // Ensure there is a toggle, if there isn't float one in the top right
  if (window.document.querySelector('.quarto-color-scheme-toggle') === null) {
    const a = window.document.createElement('a');
    a.classList.add('top-right');
    a.classList.add('quarto-color-scheme-toggle');
    a.href = "";
    a.onclick = function() { try { window.quartoToggleColorScheme(); } catch {} return false; };
    const i = window.document.createElement("i");
    i.classList.add('bi');
    a.appendChild(i);
    window.document.body.appendChild(a);
  }
  // Switch to dark mode if need be
  if (hasAlternateSentinel()) {
    toggleColorMode(true);
  } 
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const clipboard = new window.ClipboardJS('.code-copy-button', {
    target: function(trigger) {
      return trigger.previousElementSibling;
    }
  });
  clipboard.on('success', function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "Copied!");
    setTimeout(function() {
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  });
  const viewSource = window.document.getElementById('quarto-view-source') ||
                     window.document.getElementById('quarto-code-tools-source');
  if (viewSource) {
    const sourceUrl = viewSource.getAttribute("data-quarto-source-url");
    viewSource.addEventListener("click", function(e) {
      if (sourceUrl) {
        // rstudio viewer pane
        if (/\bcapabilities=\b/.test(window.location)) {
          window.open(sourceUrl);
        } else {
          window.location.href = sourceUrl;
        }
      } else {
        const modal = new bootstrap.Modal(document.getElementById('quarto-embedded-source-code-modal'));
        modal.show();
      }
      return false;
    });
  }
  function toggleCodeHandler(show) {
    return function(e) {
      const detailsSrc = window.document.querySelectorAll(".cell > details > .sourceCode");
      for (let i=0; i<detailsSrc.length; i++) {
        const details = detailsSrc[i].parentElement;
        if (show) {
          details.open = true;
        } else {
          details.removeAttribute("open");
        }
      }
      const cellCodeDivs = window.document.querySelectorAll(".cell > .sourceCode");
      const fromCls = show ? "hidden" : "unhidden";
      const toCls = show ? "unhidden" : "hidden";
      for (let i=0; i<cellCodeDivs.length; i++) {
        const codeDiv = cellCodeDivs[i];
        if (codeDiv.classList.contains(fromCls)) {
          codeDiv.classList.remove(fromCls);
          codeDiv.classList.add(toCls);
        } 
      }
      return false;
    }
  }
  const hideAllCode = window.document.getElementById("quarto-hide-all-code");
  if (hideAllCode) {
    hideAllCode.addEventListener("click", toggleCodeHandler(false));
  }
  const showAllCode = window.document.getElementById("quarto-show-all-code");
  if (showAllCode) {
    showAllCode.addEventListener("click", toggleCodeHandler(true));
  }
  function tippyHover(el, contentFn) {
    const config = {
      allowHTML: true,
      content: contentFn,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start'
    };
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      let href = ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      return note.innerHTML;
    });
  }
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const cites = ref.parentNode.getAttribute('data-cites').split(' ');
    tippyHover(ref, function() {
      var popup = window.document.createElement('div');
      cites.forEach(function(cite) {
        var citeDiv = window.document.createElement('div');
        citeDiv.classList.add('hanging-indent');
        citeDiv.classList.add('csl-entry');
        var biblioDiv = window.document.getElementById('ref-' + cite);
        if (biblioDiv) {
          citeDiv.innerHTML = biblioDiv.innerHTML;
        }
        popup.appendChild(citeDiv);
      });
      return popup.innerHTML;
    });
  }
});
</script><nav class="page-navigation"><div class="nav-page nav-page-previous">
      <a href="./20_study_overview.html" class="pagination-link">
        <i class="bi bi-arrow-left-short"></i> <span class="nav-page-text">Study Overview</span>
      </a>          
  </div>
  <div class="nav-page nav-page-next">
      <a href="./23_interested_variables.html" class="pagination-link">
        <span class="nav-page-text"><span class="chapter-number">10</span>&nbsp; <span class="chapter-title">Preliminary Data</span></span> <i class="bi bi-arrow-right-short"></i>
      </a>
  </div>
</nav><div class="modal fade" id="quarto-embedded-source-code-modal" tabindex="-1" aria-labelledby="quarto-embedded-source-code-modal-label" aria-hidden="true"><div class="modal-dialog modal-dialog-scrollable"><div class="modal-content"><div class="modal-header"><h5 class="modal-title" id="quarto-embedded-source-code-modal-label">Source Code</h5><button class="btn-close" data-bs-dismiss="modal"></button></div><div class="modal-body"><div class="">
<div class="sourceCode" id="cb1" data-shortcodes="false"><pre class="sourceCode markdown code-with-copy"><code class="sourceCode markdown"><span id="cb1-1"><a href="#cb1-1" aria-hidden="true" tabindex="-1"></a><span class="co">---</span></span>
<span id="cb1-2"><a href="#cb1-2" aria-hidden="true" tabindex="-1"></a><span class="an">title:</span><span class="co"> "Background"</span></span>
<span id="cb1-3"><a href="#cb1-3" aria-hidden="true" tabindex="-1"></a><span class="an">editor:</span><span class="co"> source</span></span>
<span id="cb1-4"><a href="#cb1-4" aria-hidden="true" tabindex="-1"></a><span class="co">---</span></span>
<span id="cb1-5"><a href="#cb1-5" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-6"><a href="#cb1-6" aria-hidden="true" tabindex="-1"></a><span class="in">```{r setup, include=FALSE}</span></span>
<span id="cb1-7"><a href="#cb1-7" aria-hidden="true" tabindex="-1"></a>knitr<span class="sc">::</span>opts_chunk<span class="sc">$</span><span class="fu">set</span>(<span class="at">echo =</span> <span class="cn">TRUE</span>,</span>
<span id="cb1-8"><a href="#cb1-8" aria-hidden="true" tabindex="-1"></a>            <span class="at">warnings =</span> <span class="cn">FALSE</span>,</span>
<span id="cb1-9"><a href="#cb1-9" aria-hidden="true" tabindex="-1"></a>            <span class="at">message =</span> <span class="cn">FALSE</span>,</span>
<span id="cb1-10"><a href="#cb1-10" aria-hidden="true" tabindex="-1"></a>            <span class="at">comment =</span> <span class="st">"#&gt;"</span>,</span>
<span id="cb1-11"><a href="#cb1-11" aria-hidden="true" tabindex="-1"></a>            <span class="co">#results = "hide",</span></span>
<span id="cb1-12"><a href="#cb1-12" aria-hidden="true" tabindex="-1"></a>            <span class="at">digits =</span> <span class="dv">4</span>,</span>
<span id="cb1-13"><a href="#cb1-13" aria-hidden="true" tabindex="-1"></a>            <span class="at">error =</span> <span class="cn">FALSE</span>)</span>
<span id="cb1-14"><a href="#cb1-14" aria-hidden="true" tabindex="-1"></a><span class="in">```</span></span>
<span id="cb1-15"><a href="#cb1-15" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-16"><a href="#cb1-16" aria-hidden="true" tabindex="-1"></a><span class="in">```{css, echo=FALSE}</span></span>
<span id="cb1-17"><a href="#cb1-17" aria-hidden="true" tabindex="-1"></a><span class="op">.</span><span class="fu">scroll</span><span class="dv">-100</span> <span class="op">{</span></span>
<span id="cb1-18"><a href="#cb1-18" aria-hidden="true" tabindex="-1"></a>  max<span class="op">-</span>height<span class="op">:</span> 300px<span class="op">;</span></span>
<span id="cb1-19"><a href="#cb1-19" aria-hidden="true" tabindex="-1"></a>  max<span class="op">-</span>width<span class="op">:</span> 1000px<span class="op">;</span></span>
<span id="cb1-20"><a href="#cb1-20" aria-hidden="true" tabindex="-1"></a>  overflow<span class="op">-</span>y<span class="op">:</span> auto<span class="op">;</span></span>
<span id="cb1-21"><a href="#cb1-21" aria-hidden="true" tabindex="-1"></a>  background<span class="op">-</span>color<span class="op">:</span> inherit<span class="op">;</span></span>
<span id="cb1-22"><a href="#cb1-22" aria-hidden="true" tabindex="-1"></a><span class="op">}</span></span>
<span id="cb1-23"><a href="#cb1-23" aria-hidden="true" tabindex="-1"></a><span class="in">```</span></span>
<span id="cb1-24"><a href="#cb1-24" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-25"><a href="#cb1-25" aria-hidden="true" tabindex="-1"></a><span class="fu">## Scientific Background {#sec-background}</span></span>
<span id="cb1-26"><a href="#cb1-26" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-27"><a href="#cb1-27" aria-hidden="true" tabindex="-1"></a><span class="fu">### Patients with AML have a sudden life-threatening illness requiring urgent therapy</span></span>
<span id="cb1-28"><a href="#cb1-28" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-29"><a href="#cb1-29" aria-hidden="true" tabindex="-1"></a>AML is an aggressive disease, characterized by an abrupt onset, an urgent need to initiate treatment, and a poor prognosis with 80% risk of death at five years <span class="co">[</span><span class="ot">@alibhai2007impact; @alibhai2015quality; @burnett2010attempts; @walter2020selection; @vey2020low</span><span class="co">]</span>. Most patients with AML are treated with chemotherapy drugs that require hospitalization due to significant toxicities and potentially life-threatening complications, such as bleeding and sepsis <span class="co">[</span><span class="ot">@rodin2013traumatic; @zimmermann2013symptom; @zittoun1999assessment; @eljawahri2015health</span><span class="co">]</span>. Patients with AML often present to medical attention without prodromal symptoms, so they are quite shocked to learn that they have a life-threatening illness and must be immediately hospitalized to receive intensive chemotherapy <span class="co">[</span><span class="ot">@alibhai2007impact; @alibhai2015quality; @burnett2010attempts</span><span class="co">]</span>.</span>
<span id="cb1-30"><a href="#cb1-30" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-31"><a href="#cb1-31" aria-hidden="true" tabindex="-1"></a><span class="fu">### Patients with AML face substantial physical and psychological symptoms</span></span>
<span id="cb1-32"><a href="#cb1-32" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-33"><a href="#cb1-33" aria-hidden="true" tabindex="-1"></a>During their hospitalization for chemotherapy, patients with AML often experience difficult physical symptoms, including fevers, fatigue, pain, insomnia, mucositis, nausea, vomiting, and diarrhea that negatively impact their quality of life (QOL) and physical function <span class="co">[</span><span class="ot">@rodin2013traumatic; @zimmermann2013symptom; @zittoun1999assessment; @eljawahri2015health; @eljawahri2019quality; @loh2019health; @wiese2018unmet</span><span class="co">]</span>. Psychological symptoms are also quite prominent in these patients, with over one-third experiencing acute stress reactions from the shock of their diagnosis and need for urgent hospitalization <span class="co">[</span><span class="ot">@rodin2013traumatic; @zimmermann2013symptom; @zittoun1999assessment; @eljawahri2015health; @eljawahri2019quality; @loh2019health; @wiese2018unmet; @nissim2013abducted; @papadopoulou2013experience; @farsi2012coping; @nissim2014bearings; @gheihman2015depression; @ghodraty2015coping; @ghodraty2015oneday</span><span class="co">]</span>. Notably, the psychological burden during this hospitalization also impacts patients’ long-term QOL, mood, and adaptation to their illness <span class="co">[</span><span class="ot">@ghodraty2015coping; @ghodraty2015oneday</span><span class="co">]</span>. Up to 40% of patients with AML suffer from post-traumatic stress symptoms due to the trauma of their diagnosis <span class="co">[</span><span class="ot">@smith1999ptsd; @jacobsen1998ptsd; @jacobsen2002predictors; @mundy2000ptsd</span><span class="co">]</span>.Therefore, addressing the physical and psychological needs of hospitalized patients with AML has the potential to improve their outcomes significantly both during their hospitalization and in the long-term.</span>
<span id="cb1-34"><a href="#cb1-34" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-35"><a href="#cb1-35" aria-hidden="true" tabindex="-1"></a><span class="fu">### Patients with AML face difficult decisions about treatment</span></span>
<span id="cb1-36"><a href="#cb1-36" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-37"><a href="#cb1-37" aria-hidden="true" tabindex="-1"></a>Many treatments are available that offer a chance of cure for patients with AML, including stem cell transplant. However, the chance of cure is small and most patients with AML unfortunately die of their illness <span class="co">[</span><span class="ot">@schlenk2017relapsed; @ganzel2018poor</span><span class="co">]</span>. Consequently, to make informed decisions about whether to receive additional treatment, patients with AML must understand their prognosis and likelihood of cure <span class="co">[</span><span class="ot">@eljawahri2020palliative; @eljawahri2018discordance</span><span class="co">]</span>. Unfortunately, data suggest that 90% of patients with AML report overly optimistic estimates of their prognosis <span class="co">[</span><span class="ot">@eljawahri2018discordance</span><span class="co">]</span>. Thus, they are unprepared to make difficult decisions that require them to balance the risks and benefits of treatments that offer an uncertain chance of cure, but will worsen their QOL and require them to spend additional time in the hospital <span class="co">[</span><span class="ot">@eljawahri2015health</span><span class="co">]</span>. Therefore, patients with AML face considerable uncertainty and often misunderstand their prognosis, limiting their ability to make informed decisions about treatment.</span>
<span id="cb1-38"><a href="#cb1-38" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-39"><a href="#cb1-39" aria-hidden="true" tabindex="-1"></a><span class="fu">### Patients with AML rarely discuss their end-of-life (EOL) care preferences</span></span>
<span id="cb1-40"><a href="#cb1-40" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-41"><a href="#cb1-41" aria-hidden="true" tabindex="-1"></a>Due to the chance of cure even after multiple therapies, oncology clinicians often defer engaging in conversations with patients with AML about their EOL care preferences <span class="co">[</span><span class="ot">@eljawahri2020palliative</span><span class="co">]</span>. As the majority of these patients die, it is imperative that oncology clinicians elicit their goals and help them make decisions about their EOL care. Unfortunately, studies show that patients with AML do not engage in timely discussions with their clinicians about their care preferences and consequently receive aggressive care at the EOL <span class="co">[</span><span class="ot">@ghodraty2015coping; @eljawahri2015utilization; @leblanc2019paradigms; @leblanc2018transfusion; @hui2014quality; @eljawahri2015utilization2; @eljawahri2020palliative; @bosshard2018economic; @klepin2014aml</span><span class="co">]</span>. Specifically, while many patients with cancer express a preference to die at home and minimize time in the hospital, 80% of patients with AML are hospitalized in the last month of life, with 50% dying in the hospital. Over half receive chemotherapy in the last month of life and 30% die in the intensive care unit (ICU) <span class="co">[</span><span class="ot">@ghodraty2015coping; @eljawahri2015utilization; @leblanc2019paradigms; @leblanc2018transfusion; @hui2014quality; @eljawahri2015utilization2; @eljawahri2020palliative; @bosshard2018economic; @klepin2014aml</span><span class="co">]</span>. Evidence-based interventions are needed to enhance patient–clinician communication and optimize EOL care for patients with AML.</span>
<span id="cb1-42"><a href="#cb1-42" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-43"><a href="#cb1-43" aria-hidden="true" tabindex="-1"></a><span class="fu">### Caregivers of patients with AML experience tremendous burden and distress</span></span>
<span id="cb1-44"><a href="#cb1-44" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-45"><a href="#cb1-45" aria-hidden="true" tabindex="-1"></a>The family and close friends (“caregivers”) of patients with AML play a critical role in their care, but also experience distress as they face the shock of the patient’s diagnosis and cope with uncertainty <span class="co">[</span><span class="ot">@eljawahri2019quality; @jia2015ptsdcaregivers; @gemmill2011caregivers; @fife2009adaptation</span><span class="co">]</span>. During the patient’s hospitalization for treatment, caregivers report a marked decline in their QOL and mood as they witness the patient struggle with side effects <span class="co">[</span><span class="ot">@eljawahri2019quality</span><span class="co">]</span>. After the patient is discharged from the hospital, the caregiver helps manage the patient’s symptoms, attends multiple oncology appointments, coordinates medical care, and prepares for subsequent hospitalizations <span class="co">[</span><span class="ot">@grover2019caregiver</span><span class="co">]</span>. Caregivers experience the highest burden and psychological distress when caring for patients with AML near the EOL <span class="co">[</span><span class="ot">@grover2019caregiver; @gerlach2019challenges</span><span class="co">]</span>. Not surprisingly, caregivers of patients with AML have disruptions in their professional and personal lives. Thus, caregivers of patients with AML would benefit from support as they navigate the patient’s illness.</span>
<span id="cb1-46"><a href="#cb1-46" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-47"><a href="#cb1-47" aria-hidden="true" tabindex="-1"></a><span class="fu">### Specialty palliative care improves outcomes for patients and their caregivers</span></span>
<span id="cb1-48"><a href="#cb1-48" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-49"><a href="#cb1-49" aria-hidden="true" tabindex="-1"></a>A growing body of evidence has demonstrated the essential role of specialty palliative care (PC) clinicians in the care of patients with advanced solid tumors <span class="co">[</span><span class="ot">@temel2010early; @temel2017integrated; @bakitas2009enable2; @bakitas2015enable3; @zimmermann2014cluster</span><span class="co">]</span>. Integrating PC with oncology care from the time of diagnosis for patients with advanced solid tumors improves patients’ QOL, psychological health, and EOL care <span class="co">[</span><span class="ot">@temel2010early; @temel2017integrated; @bakitas2009enable2; @bakitas2015enable3; @zimmermann2014cluster</span><span class="co">]</span>. Emerging data have similarly shown the benefits of specialty PC for patients with hematologic malignancies <span class="co">[</span><span class="ot">@ElJawahri2016; @ElJawahri2017; @ElJawahri2021</span><span class="co">]</span>. We recently completed a multi-site randomized trial of specialty PC versus usual care in hospitalized patients with AML <span class="co">[</span><span class="ot">@ElJawahri2021</span><span class="co">]</span>. Patients assigned to specialty PC met with a PC clinician at least twice weekly during their hospitalization for chemotherapy and subsequent hospitalizations up to one year. Specialty PC improved patients’ QOL, depression and anxiety symptoms, as well as post-traumatic stress symptoms <span class="co">[</span><span class="ot">@ElJawahri2021</span><span class="co">]</span>. Importantly, specialty PC led to clinically meaningful and sustained improvements in patients’ QOL and psychological distress for six months after initiating chemotherapy <span class="co">[</span><span class="ot">@ElJawahri2021</span><span class="co">]</span>. Patients receiving specialty PC were also more likely to discuss their EOL care preferences and less likely to receive chemotherapy in the last month of life <span class="co">[</span><span class="ot">@ElJawahri2021</span><span class="co">]</span>. Thus, involvement of specialty PC improves the experience and outcomes of patients with serious cancer and their caregivers.</span>
<span id="cb1-50"><a href="#cb1-50" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-51"><a href="#cb1-51" aria-hidden="true" tabindex="-1"></a><span class="fu">### Specialty PC is not an accessible or scalable care model</span></span>
<span id="cb1-52"><a href="#cb1-52" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-53"><a href="#cb1-53" aria-hidden="true" tabindex="-1"></a>Despite the benefits of specialty PC for patients with cancer, it is not feasible to provide this care for all patients given the limited availability of trained PC clinicians <span class="co">[</span><span class="ot">@Hui2010; @Lupu2010; @Blackhall2016</span><span class="co">]</span>. Nearly half of National Cancer Institute-designated cancer centers do not have the specialty PC workforce to provide care for their patients with cancer <span class="co">[</span><span class="ot">@Hui2010; @Lupu2010; @Blackhall2016</span><span class="co">]</span>. Due to these workforce shortages, most specialty PC is triaged to provide care for patients with incurable cancer at the EOL. Thus, despite the growing evidence base, substantial challenges limit the scalability and dissemination of this care model, especially in caring for patients with hematologic malignancies <span class="co">[</span><span class="ot">@eljawahri2020palliative; @LeBlanc2015</span><span class="co">]</span>. Moreover, oncology clinicians caring for patients with hematologic malignancies rarely consult specialty PC as they view providing PC within their scope of practice <span class="co">[</span><span class="ot">@eljawahri2020palliative; @LeBlanc2018; @ElJawahri2018; @Hui2015</span><span class="co">]</span>. Furthermore, given the complex chemotherapy regimens used to treat patients with AML and their side effects, oncology clinicians may be the ideal clinicians to address these needs <span class="co">[</span><span class="ot">@eljawahri2020palliative; @LeBlanc2018; @ElJawahri2018; @Hui2015</span><span class="co">]</span>.</span>
<span id="cb1-54"><a href="#cb1-54" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-55"><a href="#cb1-55" aria-hidden="true" tabindex="-1"></a><span class="fu">### Primary PC may be an alternative care model to specialty PC</span></span>
<span id="cb1-56"><a href="#cb1-56" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-57"><a href="#cb1-57" aria-hidden="true" tabindex="-1"></a>Training oncology clinicians to incorporate PC skills into their care practice (i.e., “primary PC”) is an alternative strategy to having specialty trained PC clinicians care for all patients with cancer. Recent studies have shown that primary PC interventions in which oncology clinicians are trained to address patient’s symptoms and engage in serious illness conversations are feasible, acceptable, and improve patient outcomes <span class="co">[</span><span class="ot">@Bernacki2019; @Paladino2019</span><span class="co">]</span>. These interventions have been shown to increase oncology clinicians’ knowledge about symptom assessment and management, as well as their comfort managing psychological distress <span class="co">[</span><span class="ot">@Epstein2017; @Reddy2019; @Schenker2015</span><span class="co">]</span>. In a cluster randomized trial in which oncology clinicians were trained in serious illness communication, patients receiving primary PC were more likely to have documented EOL discussions and reported lower anxiety and depression symptoms <span class="co">[</span><span class="ot">@Bernacki2019; @Paladino2019</span><span class="co">]</span>. While these primary PC studies are promising, it remains unknown how primary PC compares with specialty PC for improving QOL and EOL care for patients with cancer <span class="co">[</span><span class="ot">@eljawahri2020palliative; @Kavalieratos2016</span><span class="co">]</span>. Recent systematic reviews highlight the need for comparative effectiveness trials of primary versus specialty PC, to determine how to best meet the needs of patients with serious cancers, and especially those with hematologic malignancies <span class="co">[</span><span class="ot">@eljawahri2020palliative; @Kavalieratos2016</span><span class="co">]</span>.</span>
<span id="cb1-58"><a href="#cb1-58" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-59"><a href="#cb1-59" aria-hidden="true" tabindex="-1"></a><span class="fu">## Resources Available {#sec-resources}</span></span>
<span id="cb1-60"><a href="#cb1-60" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-61"><a href="#cb1-61" aria-hidden="true" tabindex="-1"></a><span class="fu">### Team Qualifications and Oversight</span></span>
<span id="cb1-62"><a href="#cb1-62" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-63"><a href="#cb1-63" aria-hidden="true" tabindex="-1"></a>Due to the size and scope of this award, we have chosen a leadership plan with dual study PIs (Drs. Areej El-Jawahri and Jennifer Temel). The dual PIs have a long-standing history of collaboration with over 20 funded research projects, and led the specialty PC trial in leukemia, which serves as the preliminary data for the current project. The dual PIs pre-existing relationship, including a history of successful collaborations on grant applications and manuscripts in high tier medical journals, and complimentary experience conducing PC trials, will ensure they provide effective leadership of this study. </span>
<span id="cb1-64"><a href="#cb1-64" aria-hidden="true" tabindex="-1"></a>The University of Colorado Data, Informatics, and Statistics Core will serve as the DCC. Dr. Colborn will provide independent leadership of the DCC and have autonomy over data integrity, data quality, and data analysis during both the study phases.. Prior studies have highlighted the unique challenges of conducting PC research trials with adequate methodological oversight and appropriate data analytical approach. Specifically, given their experience with PC research methodology, our DCC possess the necessary expertise to:</span>
<span id="cb1-65"><a href="#cb1-65" aria-hidden="true" tabindex="-1"></a><span class="ss">- </span>1) ensure adequate oversight of data collection procedures for participant-reported outcomes</span>
<span id="cb1-66"><a href="#cb1-66" aria-hidden="true" tabindex="-1"></a><span class="ss">- </span>2) address challenges of attrition and missing data due to death in PC research</span>
<span id="cb1-67"><a href="#cb1-67" aria-hidden="true" tabindex="-1"></a><span class="ss">- </span>3) implement statistical methods to address missing data</span>
<span id="cb1-68"><a href="#cb1-68" aria-hidden="true" tabindex="-1"></a><span class="ss">- </span>4) measure PC intervention fidelity. Furthermore, the DCC investigative team has substantial expertise in serving as the DCC for multiple large-scale multi-site projects. </span>
<span id="cb1-69"><a href="#cb1-69" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-70"><a href="#cb1-70" aria-hidden="true" tabindex="-1"></a><span class="fu">### Other Resources</span></span>
<span id="cb1-71"><a href="#cb1-71" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-72"><a href="#cb1-72" aria-hidden="true" tabindex="-1"></a>We solicited participating sites through The Palliative Care Research Cooperative (PCRC) with medium to large leukemia practices to ensure that each site would see a minimum of 50 new patients with AML per year. We also chose sites that have an inpatient specialty PC practice to accommodate patients who are randomized to receiving specialty PC. Prior to submitting this project, we conducted interviews with 35 sites and chose 20 sites with appropriate infrastructure to conduct the study. As many of these sites are tertiary care centers, we estimate that 15% of new patients will be second-opinion consultations only and therefore ineligible. We estimate that each site will have a minimum of 40 eligible patients per year. At MGH, we have enrolled 70% of eligible patients with AML in our prior PC trials. Since the proposed study is a cluster randomized trial, we anticipate that enrollment rates will be higher than prior studies, as patients are not being randomized. Nonetheless, we conservatively estimate that at least 60% of eligible patients will enroll in the study. In our prior studies, 60% of patients who enrolled had a caregiver who was willing to participate, so we conservatively estimate caregiver enrollment rates of approximately 50%. Therefore, we are confident in our ability to achieve our proposed enrollment goals for patients and caregivers. </span></code><button title="Copy to Clipboard" class="code-copy-button"><i class="bi"></i></button></pre></div>
</div></div></div></div></div>
</div> <!-- /content -->
<footer class="footer"><div class="nav-footer">
    <div class="nav-footer-left">This Analytic Plan was written by Randy.</div>   
    <div class="nav-footer-right">This book was built with <a href="https://quarto.org/">Quarto</a>.</div>
  </div>
</footer>


</body></html>